Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 10
2019 10
2020 4
2021 4
2022 8
2023 9
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Poverty and inequality in real-world schizophrenia: a national study.
Fond GB, Yon DK, Tran B, Mallet J, Urbach M, Leignier S, Rey R, Misdrahi D, Llorca PM, Schürhoff F, Berna F, Boyer L. Fond GB, et al. Among authors: leignier s. Front Public Health. 2023 Oct 31;11:1182441. doi: 10.3389/fpubh.2023.1182441. eCollection 2023. Front Public Health. 2023. PMID: 38026279 Free PMC article.
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G, Godin O, Schürhoff F, Berna F, André M, Aouizerate B, Capdevielle D, Chereau I, D' Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Szoke A, Urbach M, Vidailhet P, Leboyer M, Boyer L, Llorca PM; FACE-SZ group. Fond G, et al. Among authors: leignier s. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109927. doi: 10.1016/j.pnpbp.2020.109927. Epub 2020 Mar 12. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32173456 Review.
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.
Vidal N, Roux P, Urbach M, Belmonte C, Boyer L, Capdevielle D, Clauss-Kobayashi J, D'Amato T, Dassing R, Dubertret C, Dubreucq J, Fond G, Honciuc RM, Leignier S, Llorca PM, Mallet J, Misdrahi D, Pignon B, Rey R, Schürhoff F, Tessier A; FACE-SZ (FondaMental Academic Centers of Expertise—Schizophrenia) Group; Passerieux C, Brunet-Gouet E. Vidal N, et al. Among authors: leignier s. Front Pharmacol. 2024 Jun 12;15:1403093. doi: 10.3389/fphar.2024.1403093. eCollection 2024. Front Pharmacol. 2024. PMID: 38933674 Free PMC article.
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Dondé C, Coulon N, Turbé H, Andre M, Boyer L, Capdevielle D, Chereau I, Dassing R, Dorey JM, Dubertret C, Leignier S, Llorca PM, Misdrahi D, Passerieux C, Pignon B, Rey R, Schorr B, Schürhoff F, Urbach M, Fond G, Mallet J. Dondé C, et al. Among authors: leignier s. Schizophr Res. 2024 Feb;264:105-112. doi: 10.1016/j.schres.2023.12.010. Epub 2023 Dec 20. Schizophr Res. 2024. PMID: 38128341
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Among authors: leignier s. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Roux P, Faivre N, Urbach M, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Dubertret C, Dubreucq J, Fond G, Lançon C, Leignier S, Mallet J, Misdrahi D, Pires S, Schneider P, Schurhoff F, Yazbek H, Zinetti-Bertschy A, Passerieux C, Brunet-Gouet E. Roux P, et al. Among authors: leignier s. Schizophr Res. 2023 Feb;252:48-55. doi: 10.1016/j.schres.2022.12.037. Epub 2023 Jan 7. Schizophr Res. 2023. PMID: 36623435
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. Among authors: leignier s. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, André M, Capdevielle D, Chereau I, Coulon N, Dassing R, Dubertret C, Etain B, Leignier S, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Urbach M, Schürhoff F, Leboyer M, Fond G. Godin O, et al. Among authors: leignier s. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110641. doi: 10.1016/j.pnpbp.2022.110641. Epub 2022 Sep 17. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36122839
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.
Garosi A, Sunhary de Verville PL, Etchecopar-Etchart D, Richieri R, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Dorey JM, Dubertret C, Coulon N, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Szoke A, Urbach M, Leboyer M, Llorca PM, Lançon C, Boyer L, Fond G; Collaborators : the FACE-SZ (Fonda Mental Academic Centers of Expertise for Schizophrenia) group. Garosi A, et al. Among authors: leignier s. Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):825-837. doi: 10.1007/s00406-022-01449-x. Epub 2022 Jul 19. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35852617
Gender differences in psychosocial function and self-reported health status in late-diagnosed autistic adults: results from the FACE-ASD national cohort.
Dubreucq J, Coutelle R, Lajnef M, Godin O, Amestoy A, Atzori P, Baleyte JM, Bonnot O, Bouvard M, Coulon N, Da Fonseca D, Demily C, Delorme R, Fabrowski M, Givaudan M, Gollier-Briant F, Guenolé F, Humeau E, Leignier S, Lejuste F, Levy C, Rabot J, Schröder CM, Valette M; FACE-ASD (FondaMental Advanced Centers of Expertise for Autism Spectrum Disorder) Groups; Leboyer M, Speranza M. Dubreucq J, et al. Among authors: leignier s. Psychol Med. 2023 Sep;53(12):5674-5684. doi: 10.1017/S0033291722002902. Epub 2022 Sep 30. Psychol Med. 2023. PMID: 36177672
36 results